Klin Farmakol Farm. 2005;19(4):206-210

THERAPY MONITORING OF ASTHMA PATIENTS IN THE PHARMACY

Božena Macešková, Daniela Fridrichová
Ústav aplikované farmacie, Farmaceutická fakulta VFU, Brno

The therapy of 16 patients with asthma was monitored within an 8-month period during which the patiens were visiting the same pharmacy. Their medication problems, imperfection in the inhalation technique, and manifestations and reasons of non-compliance were identified in the course of four sessions. The changes in their understanding of the illness and objective changes in their health condition were detected using semistructured interviews. Mistakes in the use of different types of inhalators were minimized, and a training in cleaning the inhalators and in finding out the number of the remaining doses was provided. Eight patients (50.0 %) were feeling subjectively better at the end of the monitoring, 12 (75.0 %) found the education provided by a pharmacist to be useful. Compliance with the prescribed medication was improved in all the three monitored aspects. The patients have a continuing interest in receiving advice from the pharmacist. The lack of time and privacy in pharmacies are seen as major obstacles by the patients. The physicians of 9 of the participating patients found an improvement in the inhalation technique in 6 patients (66.7 %) and an improvement in the knowledge about the illness in 7 patients (77.8 %). Asthma is an example of an illness in which the pharmacist can contribute to the optimization of the therapy and to a better quality of outcomes.

Keywords: Key words: therapy monitoring, asthma, pharmacy, physician, pharmacist.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Macešková B, Fridrichová D. THERAPY MONITORING OF ASTHMA PATIENTS IN THE PHARMACY. Klin Farmakol Farm. 2005;19(4):206-210.
Download citation

References

  1. Pohunek P. Výskyt bronchiálního astmatu ve světě a u nás. Alergie 2003 (suppl 1); 5: 7-14.
  2. název stránky www.uzis.cz, říjen 2005.
  3. Špičák V, Kašák V, Pohunek P. Strategie diagnostiky, prevence a léčby průduškového astmatu v ČR. 1. vyd. Praha: Jalna, 1996, 112 s.
  4. Herborg H, Soendergaard B, Frokjaer B. Improving drug therapy for patients with asthma- part 1. J Am Pharm Assoc 2001; 41 (4): 539-550. Go to original source... Go to PubMed...
  5. Grainger-Russeau TJ, Miralles MA, Hepler CD et all. Therapeutic outcomes monitoring: application of pharmaceutical care guidelines to community pharmacy. J Am Pharm Assoc 1997; 37 (6): 647-661. Go to original source... Go to PubMed...
  6. Kašák V, Špičák V. Globální strategie léčby astmatu - GINA - vyd. 2002. Alergie 2002 (suppl 2); 4: 9-14.
  7. název stránky www.ginasthma.com, říjen 2005.
  8. název stránky www.cipa.cz, říjen 2005.
  9. Pouk N, Zatloukal P. Současná terapie asthma bronchiale u dospělých. Remedia 2002; 12 (3): 186-192.
  10. Krtička F. Naše medicína z pohledu demokracie a etiky, etika ve vztahu pacient - lékař. Prakt Lék 2002; 82 (11): 656-659.
  11. Novák J. Aktuální otázky o astmatu a jeho léčbě. Alergie 2002; 4 (3): 211-221.
  12. Astma v ČR, Pohled z druhé strany. Alergie 2002 (suppl 1); 4: 3-19.
  13. Lorentzon S, Almhult M. Vedení léčby astmatu v systému primární péče. Respirace 1997; 3 (1): 2-4.
  14. Špičák V, Kašák V, Pohunek P. Kapesní průvodce diagnostikou, prevencí a léčbou průduškového astmatu v ČR, příručka pro lékaře a zdravotníky. 2. vyd. Praha: Jalna, 1999, 32 s.
  15. Král B. Několik otazníků nad edukací dospělých astmatiků. Respirace 1998; 4 (2): 8-11.
  16. Komrska J. Farmaceutická starostlivost - budúcnosť slovenskej farmácie? Farm Obzor 2000; 69 (2): 31-35.
  17. Szucsová S, Sýkora J, Slaný J. Lékárenská starostlivosť a správná lekárenská prax - východiská a perspektívy. Farm Obzor 1995; 64 (6): 147-151.
  18. Práznovcová L. Lékové záznamy pacienta. www.pace.cz, 2003 (poslední vstup říjen 2005).
  19. Kolář J, Szuscová S. K problematice správné farmakoterapie. Čes a Slov Farm 2000; 49 (1): 13-20.
  20. Pharmacy based asthma services. Europharm forum WHO 1998. www.euro.who. int, říjen 2005.
  21. Herborg H, Sondergaard B, Frokjaer B. Quality improvement of drug therapy for asthma patients. Pracovní materiál. Danish College of Pharmacy Practice and University of Florida. 1993, 8 s.
  22. Herborg H, Sondergaard B, Jorgensen T. Improving drug therapy for patients with asthma - part 2. J Am Pharm Assoc 2001; 41 (4): 551-559. Go to original source... Go to PubMed...
  23. Narhi U, Airskanem A, Tanskanen M, et al. TOM by community pharmacists for improving clinical outcomes in asthma. J Clin Pharm Ther 2000; 25 (3): 177-183. Go to original source... Go to PubMed...
  24. Disman M. Jak se vyrábí sociologická znalost. 1. vyd. Praha: Karolinum, 1993: 350 s.
  25. Bryman A. Quantity and quality in social research. 5. vyd. London and New York: Routledge, 1996: 198 s.
  26. Petersen LD. Information needs in practicing pharmaceutical care as seen by a Danish pharmacist. FIP Word Congress, Stockholm 1995.
  27. Kolář J, Szucsová S. Konzultační činnost. Farm Obzor 2000; 69 (1): 3-12.
  28. Ptejte se na své léky. WHO Europe Project realizovaný v ČR Českou lékárnickou komorou 2002 ().
  29. Kradjan WA, Schultz R, Christensen DB, et al. Patients' percieved benefit from and satisfaction with asthma- related pharmacy services. J Am Pharm Assoc 1991; 39 (5): 658-666. Go to original source... Go to PubMed...
  30. Venkatraman KS, Mandhavan SS. Barriers and facilitators to provision of pharmaceutical care in rural community practice. J Soc Adm Pharm 1997; 14 (4): 208-221.




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.